U.S. flag

An official website of the United States government

NM_000159.4(GCDH):c.1213dup (p.Met405fs) AND Glutaric aciduria, type 1

Germline classification:
Pathogenic/Likely pathogenic (3 submissions)
Last evaluated:
May 13, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001377591.10

Allele description [Variation Report for NM_000159.4(GCDH):c.1213dup (p.Met405fs)]

NM_000159.4(GCDH):c.1213dup (p.Met405fs)

Gene:
GCDH:glutaryl-CoA dehydrogenase [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
19p13.13
Genomic location:
Preferred name:
NM_000159.4(GCDH):c.1213dup (p.Met405fs)
HGVS:
  • NC_000019.10:g.12897833dup
  • NG_009292.1:g.11674dup
  • NG_033049.1:g.26440dup
  • NM_000159.4:c.1213dupMANE SELECT
  • NM_013976.5:c.1213dup
  • NP_000150.1:p.Met405fs
  • NP_039663.1:p.Met405fs
  • NC_000019.9:g.13008646_13008647insA
  • NC_000019.9:g.13008647dup
  • NR_102316.1:n.1376dup
  • NR_102317.1:n.1594dup
Protein change:
M405fs
Links:
dbSNP: rs1377352983
NCBI 1000 Genomes Browser:
rs1377352983
Molecular consequence:
  • NM_000159.4:c.1213dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_013976.5:c.1213dup - frameshift variant - [Sequence Ontology: SO:0001589]
  • NR_102316.1:n.1376dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NR_102317.1:n.1594dup - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Glutaric aciduria, type 1
Synonyms:
GA I; Glutaryl-CoA dehydrogenase deficiency; Glutaric acidemia type I; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0009281; MedGen: C0268595; Orphanet: 25; OMIM: 231670

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001574961Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Aug 28, 2020)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV002086998Natera, Inc.
no assertion criteria provided
Likely pathogenic
(Jun 29, 2020)
germlineclinical testing

SCV004199244Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 13, 2023)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The human glutaryl-CoA dehydrogenase gene: report of intronic sequences and of 13 novel mutations causing glutaric aciduria type I.

Schwartz M, Christensen E, Superti-Furga A, Brandt NJ.

Hum Genet. 1998 Apr;102(4):452-8.

PubMed [citation]
PMID:
9600243

Mutation analysis in glutaric aciduria type I.

Zschocke J, Quak E, Guldberg P, Hoffmann GF.

J Med Genet. 2000 Mar;37(3):177-81.

PubMed [citation]
PMID:
10699052
PMCID:
PMC1734541
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001574961.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Thr429 amino acid residue in GCDH. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9600243, 10699052, 24973495). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. This variant has not been reported in the literature in individuals with GCDH-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change results in a premature translational stop signal in the GCDH gene (p.Met405Asnfs*14). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 34 amino acids of the GCDH protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Natera, Inc., SCV002086998.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004199244.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024